A remarkable advantage of CAR T cells is the antigen-specific triggering of T cell-mediated cytolytic responses via the release of lytic proteins such as granzyme B (GrB) (34) independent of the MHC-I expression on the tumor (37), a relatively high ex vivo expansion rate and the high transduction efficacy of T cells. The gene discussed is GZMB; the disease is neoplasm.